Articles in this section

• EASL Policy Statement: Drug Use and the Global Hepatitis C Elimination Goal

  

  August 2020—The European Association for the Study of the Liver (EASL) made a bold policy statement, based on a science-based policy brief, to lift treatment barriers and decriminalize drug use as part of elimination strategies.
  EASL recommends “that all barriers to the uptake of the continuum (...) More

  13 February 2021

• Harnessing the COVID-19 Response Towards Hepatitis C Elimination

  

  New York, Paris, Lisbon, February 1, 2021 — On Wednesday, February 3, 2021, Treatment Action Group, Médecins du Monde, hepCoalition, and the UNITE network convene a virtual policy dialogue among parliamentarians, global civil society organizations, and community leaders to share how COVID-19 has (...) More

  1 February 2021

• AFRICAN DECLARATION TO ELIMINATE HEPATITIS C AND IMPROVE THE HEALTH OF PEOPLE WHO USE DRUGS Cape Town, South Africa, 20 February 2020

  

  If your organization would like to sign on, please contact INHSU: info@inhsuafrica2020.com
  We, the community of people working to eliminate hepatitis C in the African region express alarm regarding the increasing impact of drug use, hepatitis C, and other viral co-infections (including HIV and (...) More

  21 February 2020

• #FreeChangsha3: Wrongfully Detained HIV/Viral Hepatitis Activists

  

  Three Chinese lawyers and advocates, Cheng Yuan, Wu Gejianxiong, and Liu Yongze, who work on employment discrimination and disability justice for people living with HIV and viral hepatitis, have been wrongfully detained in Hunan, China since 22 July 2019. More

  19 August 2019

• Hepatitis C cure, sofosbuvir, turns 5 years old: The vast majority of people still have not been treated

  

  Advocates scandalized that Gilead’s hepatitis C profits have raked in US$25.8 billion, which could have treated everyone while still earning US$16 billion in profits.
  6 December 2018, Paris, France, New York, NY— People living with hepatitis C, access to medicines activists, and the medical (...) More

  6 December 2018